Determinants of underdiagnosis of COPD in national and international surveys

Bernd Lamprecht, Joan B. Soriano, Michael Studnicka, Bernhard Kaiser, Lowie E. Vanfleteren, Louisa Gnatiuc, Peter Burney, Marc Miravitlles, Francisco Garcîa-Rio, Kaveh Akbari, Julio Ancochea, Ana M. Menezes, Rogelio Perez-Padilla, Maria Montes De Oca, Carlos A. Torres-Duque, Andres Caballero, Mauricio González-Garcîa, Sonia Buist, Ana Maria B. Menezes, Carlos TalamoMaria Victorina Lopez-Varela, Adriana Muino, Gonzalo Valdivia, Carmem Lisboa, Jose Roberto B. Jardim

Research output: Contribution to journalArticlepeer-review

153 Scopus citations

Abstract

Background: COPD ranks within the top three causes of mortality in the global burden of disease, yet it remains largely underdiagnosed. We assessed the underdiagnosis of COPD and its determinants in national and international surveys of general populations. Methods: We analyzed representative samples of adults aged ≥ 40 years randomly selected from well-defined administrative areas worldwide (44 sites from 27 countries). Postbronchodilator FEV 1 /FVC < lower limit of normal (LLN) was used to define chronic airflow limitation consistent with COPD. Undiagnosed COPD was considered when participants had postbronchodilator FEV 1 /FVC < LLN but were not given a diagnosis of COPD. Results: Among 30,874 participants with a mean age of 56 years, 55.8% were women, and 22.9% were current smokers. Population prevalence of (spirometrically defined) COPD ranged from 3.6% in Barranquilla, Colombia, to 19.0% in Cape Town, South Africa. Only 26.4% reported a previous lung function test, and only 5.0% reported a previous diagnosis of COPD, whereas 9.7% had a postbronchodilator FEV 1 /FVC < LLN. Overall, 81.4% of (spirometrically defined) COPD cases were undiagnosed, with the highest rate in Ile-Ife, Nigeria (98.3%) and the lowest rate in Lexington, Kentucky (50.0%). In multivariate analysis, a greater probability of underdiagnosis of COPD was associated with male sex, younger age, never and current smoking, lower education, no previous spirometry, and less severe airflow limitation. Conclusions: Even with substantial heterogeneity in COPD prevalence, COPD underdiagnosis is universally high. Because effective management strategies are available for COPD, spirometry can help in the diagnosis of COPD at a stage when treatment will lead to better outcomes and improved quality of life.

Original languageEnglish (US)
Pages (from-to)971-985
Number of pages15
JournalCHEST
Volume148
Issue number4
DOIs
StatePublished - Oct 1 2015

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Determinants of underdiagnosis of COPD in national and international surveys'. Together they form a unique fingerprint.

Cite this